148 related articles for article (PubMed ID: 22551918)
1. Identification of t(1;19)(q12;p13) and ploidy changes in an ependymosarcoma: a cytogenetic evaluation.
Tabbarah AZ; Carlson AW; Oviedo A; Ketterling RP; Rodriguez FJ
Clin Neuropathol; 2012; 31(3):142-5. PubMed ID: 22551918
[TBL] [Abstract][Full Text] [Related]
2. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
[TBL] [Abstract][Full Text] [Related]
3. Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study.
Rodriguez FJ; Scheithauer BW; Perry A; Oliveira AM; Jenkins RB; Oviedo A; Mork SJ; Palmer CA; Burger PC
Am J Surg Pathol; 2008 May; 32(5):699-709. PubMed ID: 18347506
[TBL] [Abstract][Full Text] [Related]
4. Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia.
Shearer BM; Flynn HC; Knudson RA; Ketterling RP
Br J Haematol; 2005 Apr; 129(1):45-52. PubMed ID: 15801954
[TBL] [Abstract][Full Text] [Related]
5.
Pujadas E; Chen L; Weingart JD; Orr B; Ozer BH; Holdhoff M; Rodriguez FJ
Clin Neuropathol; 2020; 39(4):179-187. PubMed ID: 32017698
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia.
Dahlback HS; Gorunova L; Micci F; Scheie D; Brandal P; Meling TR; Heim S
Cytogenet Genome Res; 2011; 134(2):88-95. PubMed ID: 21555877
[TBL] [Abstract][Full Text] [Related]
7. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
[TBL] [Abstract][Full Text] [Related]
8. Gliosarcoma arising from an anaplastic ependymoma: a case report of a rare entity.
Behling E; Birbe R; Veznadaroglu E; Andrews DW; Flanders A; Kenyon LC
Hum Pathol; 2004 Apr; 35(4):512-6. PubMed ID: 15116335
[TBL] [Abstract][Full Text] [Related]
9. Rapid spontaneous malignant progression of supratentorial tanycytic ependymoma with sarcomatous features - "Ependymosarcoma".
Vajtai I; Kuhlen D; Kappeler A; Mariani L; Zimmermann A; Paulus W
Pathol Res Pract; 2010 Jul; 206(7):493-8. PubMed ID: 19853384
[TBL] [Abstract][Full Text] [Related]
10. Translocation 1;19 in two brain tumors.
Vagner-Capodano AM; Mugneret F; Zattara-Cannoni H; Gabert J; Favre B; Figarella-Branger D; Gentet JC; Lena G; Bernard JL
Cancer Genet Cytogenet; 1997 Aug; 97(1):1-4. PubMed ID: 9242210
[TBL] [Abstract][Full Text] [Related]
11. Gliosarcoma arising from an oligodendroglioma (oligosarcoma).
Hiniker A; Hagenkord JM; Powers MP; Aghi MK; Prados MD; Perry A
Clin Neuropathol; 2013; 32(3):165-70. PubMed ID: 23254140
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatous evolution of oligodendroglioma ("oligosarcoma"): confirmatory report of an uncommon pattern of malignant progression in oligodendroglial tumors.
Vajtai I; Vassella E; Hewer E; Kappeler A; Reinert MM
Pathol Res Pract; 2012 Dec; 208(12):750-5. PubMed ID: 23102810
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic ependymoma with ependymoblastic multilayered rosettes.
Nobusawa S; Suzuki A; Nagaishi M; Isoda K; Ikota H; Yokoo H; Hirato J; Nakazato Y
Hum Pathol; 2013 Nov; 44(11):2597-602. PubMed ID: 23791209
[TBL] [Abstract][Full Text] [Related]
14. Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.
Rodriguez FJ; Mota RA; Scheithauer BW; Giannini C; Blair H; New KC; Wu KJ; Dickson DW; Jenkins RB
Brain Pathol; 2009 Oct; 19(4):623-9. PubMed ID: 18710393
[TBL] [Abstract][Full Text] [Related]
15. Gliosarcoma developing from an irradiated ependymoma.
Kepes JJ; Bastian FO; Weber ED
Acta Neuropathol; 1996 Nov; 92(5):515-9. PubMed ID: 8922064
[TBL] [Abstract][Full Text] [Related]
16. Gliosarcoma: an immunohistochemical, ultrastructural and fluorescence in situ hybridization study.
Horiguchi H; Hirose T; Kannuki S; Nagahiro S; Sano T
Pathol Int; 1998 Aug; 48(8):595-602. PubMed ID: 9736406
[TBL] [Abstract][Full Text] [Related]
17. Constitutional de novo t(1;22)(p22;q11.2) and ependymoma.
Park JP; Chaffee S; Noll WW; Rhodes CH
Cancer Genet Cytogenet; 1996 Feb; 86(2):150-2. PubMed ID: 8603343
[TBL] [Abstract][Full Text] [Related]
18. Multiple chromosomal monosomies are characteristic of giant cell ependymoma.
Dahlback HS; Brandal P; Krossnes BK; Fric R; Meling TR; Meza-Zepeda LA; Danielsen HE; Heim S
Hum Pathol; 2011 Dec; 42(12):2042-6. PubMed ID: 21683982
[TBL] [Abstract][Full Text] [Related]
19. Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1).
Yamamoto K; Nagata K; Tsurukubo Y; Inagaki K; Ono R; Taki T; Hayashi Y; Hamaguchi H
Cancer Genet Cytogenet; 2002 Aug; 137(1):64-7. PubMed ID: 12377416
[TBL] [Abstract][Full Text] [Related]
20. Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma.
Rousseau E; Palm T; Scaravilli F; Ruchoux MM; Figarella-Branger D; Salmon I; Ellison D; Lacroix C; Chapon F; Mikol J; Vikkula M; Godfraind C
Mol Cancer; 2007 Jul; 6():47. PubMed ID: 17626628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
